Pfizer’s vaccine to protect newborns from respiratory syncytial virus, or RSV, by vaccinating their moms late in pregnancy cuts the risk that infants will need to see a doctor or be admitted to the ...
An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.
IFLScience on MSN
Is mRNA The Future Of Flu Shots? New Vaccine 34.5 Percent More Effective Than Standard Shots In Trials
A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The Pfizer-developed vaccine was found to be 34.5 percent more effective than ...
April 5 (Reuters) - Pfizer Inc's PFE.N experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing severe infections in infants when given to expecting mothers in the second ...
An RSV vaccine developed by Pfizer provides safe and effective protection in both seniors and newborns, clinical trial results show. The vaccine is 86% effective in protecting older adults against RSV ...
Newly released data from Pfizer/BioNTech’s ongoing study of their COVID-19 vaccine suggests it is effective at preventing serious symptoms and death at least six months after vaccination. The ...
In a recent study published in The Lancet Regional Health Western Pacific, researchers compare the immunogenicity, reactogenicity, and safety of a half-dose Pfizer-BioNTech BNT162b2 coronavirus ...
Erin Morgan, a registered nurse, administers the Pfizer COVID-19 vaccine to 14-year-old Zach Bilyj of Wake Forest, North Carolina, during a vaccination clinic. Kids ages 12 and up are eligible for the ...
Shares in video-call software Zoom plunged by around 15 percent this morning as news broke about a promising COVID-19 vaccine candidate. Pharmaceutical companies Pfizer and BioNTech said today that ...
NEW YORK (Reuters) - Pfizer Inc's experimental pill for rheumatoid arthritis appeared to be effective and well-tolerated in a mid-stage clinical study, the drugmaker said. The drug, known as ...
A COVID-19 vaccine may be on the way. Albert Bourla, Pfizer Pharmaceuticals’ CEO, claims that a vaccine under development to protect people from COVID-19 could be 90% effective, CNN reports. “What we ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results